Product information
| Price | €175, €275, €395 |
|---|---|
| Size | 20 µl/µg | 50 µl/µg | 100 µl/µg |
| Short name | Akt2 Antibody |
| Host | Rabbit |
| Isotype | IgG |
| Target protein | AKT2 |
| Recommended applications | IHC-p, WB |
| Reactivity | Human, Mouse, Rat |
| Immunogen | Recombinant Protein of Akt2 |
| Purification | The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Formulation | PBS; pH 7.4; containing 0.02% sodium azide as Preservative and 50% Glycerol. |
| Storage | -20°C for 1 year |
| Product code | MB-AP11846 |
Additional information
Prev
Next
AKT2 is a putative oncogene encoding a protein belonging to a subfamily of serine/threonine kinases containing SH2-like (Src homology 2-like) domains. AKT2 was shown to be amplified and overexpressed in 2 of 8 ovarian carcinoma cell lines and 2 of 15 primary ovarian tumors. Overexpression contributes to the malignant phenotype of a subset of human ductal pancreatic cancers. AKT serine/threonine kinase 2 is a general protein kinase capable of phophorylating several known proteins.
AKT2, RAC-beta serine/threonine-protein kinase, Protein kinase Akt-2, Protein kinase B beta, PKB beta, RAC-PK-beta
Human: P31751, Mouse: Q60823, Rat: P47197
Human: 208, Mouse: 11652, Rat: 25233
